MVP signs significant Manufacturing Development Project with CSIRO
5 June 2017
ASX ANNOUNCEMENT
MVP signs significant Manufacturing Development Project with CSIRO.
Medical Developments International Limited (ASX: MVP) is delighted to announce it has signed an agreement with Australia’s preeminent science and research body the Commonwealth Scientific and Industrial Research Organisation (CSIRO) to develop new manufacturing technologies for pharmaceutical products.
This agreement extends MVP’s existing partnership with the CSIRO and the technologies developed in that partnership. Our collective ambition is to develop the next generation of manufacturing technologies to make “small molecule” pharmaceutical products at a significantly reduced cost and improved quality, compared with traditional processes. Work has already begun and the preliminary results are very encouraging.
Please refer to the following link for the full release MVP signs significant Manufacturing Development Project with CSIRO